Literature DB >> 6323201

Biological and biochemical characterization of an SV40-transformed xeroderma pigmentosum cell line.

B Royer-Pokora, W D Peterson, W A Haseltine.   

Abstract

We have isolated a subclone of the SV40-transformed xeroderma pigmentosum (XP) cell line SV40XP12RO. The cell line, designated M1, is highly sensitive to ultraviolet light and is deficient in unscheduled DNA synthesis. The isoenzyme, HLA profile and karyotype of the cell line is presented. The structure and function of the resident SV40 genome is analysed. The M1 clone contains a complete copy of the SV40 genome flanked by partial SV40-DNA copies in a head-to-tail arrangement. The large T-antigen is defective in the ability to induce SV40-DNA replication. The M1 subclone is an efficient recipient of DNA in transfection experiments. Transfection of these cells with the pSV2gpt plasmid shows that the M1 subclone is as efficient as the NIH 3T3 cell line in uptake and expression of foreign DNA. This cell line should be suitable for genetic analysis of the xeroderma pigmentosum defect. It should also be useful for the study of gene expression in human cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323201     DOI: 10.1016/0014-4827(84)90391-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Development of monoclonal antibodies to human microsomal epoxide hydrolase and analysis of "preneoplastic antigen"-like molecules.

Authors:  Hongying Duan; Kazunori Yoshimura; Nobuharu Kobayashi; Kazuo Sugiyama; Jun-Ichi Sawada; Yoshiro Saito; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

Authors:  L Lightstone; R Hargreaves; G Bobek; M Peterson; G Aichinger; G Lombardi; R Lechler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

3.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Molecular cloning and characterization of a mammalian excision repair gene that partially restores UV resistance to xeroderma pigmentosum complementation group D cells.

Authors:  J E Arrand; N M Bone; R T Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  A highly conserved endonuclease activity present in Escherichia coli, bovine, and human cells recognizes oxidative DNA damage at sites of pyrimidines.

Authors:  P W Doetsch; W D Henner; R P Cunningham; J H Toney; D E Helland
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

6.  Ataxia telangiectasia resists gene cloning: an account of parameters determining gene transfer into human recipient cells.

Authors:  H Lohrer; M Blum; P Herrlich
Journal:  Mol Gen Genet       Date:  1988-06

7.  gamma-H2AX formation in response to interstrand crosslinks requires XPF in human cells.

Authors:  Seiki Mogi; Dennis H Oh
Journal:  DNA Repair (Amst)       Date:  2006-05-05

8.  DNA polymerase eta reduces the gamma-H2AX response to psoralen interstrand crosslinks in human cells.

Authors:  Seiki Mogi; Christina E Butcher; Dennis H Oh
Journal:  Exp Cell Res       Date:  2007-11-17       Impact factor: 3.905

9.  A deletion in the simian virus 40 large T antigen impairs lytic replication in monkey cells in vivo but enhances DNA replication in vitro: new complementation function of T antigen.

Authors:  C Maulbecker; I Mohr; Y Gluzman; J Bartholomew; M Botchan
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Stable surface expression of invariant chain prevents peptide presentation by HLA-DR.

Authors:  P A Roche; C L Teletski; D R Karp; V Pinet; O Bakke; E O Long
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.